HypeCheck
← All Ingredients Anti Inflammatory

Evening Primrose Oil

Also known as: EPO, Oenothera biennis, evening primrose, gamma-linolenic acid oil, GLA oil

Effective Dosage

1000-2000 mg daily (oral or vaginal depending on use)

What the Science Says

Evening primrose oil (EPO) is a plant-derived oil pressed from the seeds of the evening primrose flower. It is rich in gamma-linolenic acid (GLA), an omega-6 fatty acid with anti-inflammatory properties. Clinical trials show it can meaningfully reduce pain in diabetic neuropathy at 1000–2000 mg daily, and vaginal application has been shown to help ripen the cervix before labor or gynecological procedures. Early evidence also suggests it may reduce inflammatory markers like IL-6 when combined with fish oil in cancer patients undergoing chemotherapy.

What It Doesn't Do

Not proven to reliably treat eczema on its own — a major systematic review found the evidence for EPO in atopic dermatitis remains limited. No solid evidence it relieves menopausal hot flashes despite being one of the most popular supplements used for that purpose. Won't replace standard diabetes medications. Not a cancer treatment. No evidence it detoxifies the body or boosts immunity on its own.

Evidence-Based Benefits

Evening primrose oil is rich in gamma-linolenic acid (GLA), which has been shown to help alleviate symptoms of premenstrual syndrome (PMS) and may support skin health by improving hydration and reducing inflammation. Some studies suggest it may also help with conditions like eczema and rheumatoid arthritis.

Strong Evidence

Effective at: 500-3000 mg daily

Source: auto-research

Absorption & Bioavailability

Unknown from provided studies — no pharmacokinetic data reported. Vaginal administration appears to produce local cervical effects; oral GLA from EPO was shown to alter plasma fatty acid profiles in one trial, suggesting reasonable absorption.

Red Flags to Watch For

  • Vaginal use during pregnancy should only be done under medical supervision — studies were conducted in clinical settings, not at home
  • Most studies are small (20–82 participants) and short-term; long-term safety data is lacking
  • EPO is widely marketed for menopause and eczema, but the provided evidence does not strongly support these uses
  • Combined with blood thinners or anticoagulants, GLA-rich oils may increase bleeding risk — not addressed in provided studies
  • Many products on the market (1000+ registered supplements) vary widely in GLA content and quality — standardization is not guaranteed

Research Sources

  • PubMed
  • NIH DSLD

This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-04-06